Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rita N Barcia

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cytotherapy|January 8, 2025
Smart Cell Therapy: an industry perspective on macrophages as living drugsDavid T Rodgers, Tatiana Novobrantseva, Rita N Barcia
Experimental Gerontology|January 5, 2002
Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cellsNicola S Dennett, Rita N Barcia, Julie D McLeod
Stem Cells Translational Medicine|May 16, 2019
Convergence of Cell Pharmacology and Drug DeliveryAyesha Aijaz, Natalie Vaninov, Ashley Allen, et al.
Stem Cells Translational Medicine|February 2, 2021
Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular applicationBrian O'Rourke, Sunny Nguyen, Arno W Tilles, et al.
Investigative Ophthalmology & Visual Science|September 18, 2010
Spontaneous bacterial keratitis in CD36 knockout miceJulia Klocke, Rita N Barcia, Susan Heimer, et al.
Scientific Reports|September 18, 2020
Author Correction: Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune CellsAshley Allen, Natalie Vaninov, Matthew Li, et al.
Scientific Reports|June 25, 2020
Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune CellsAshley Allen, Natalie Vaninov, Matthew Li, et al.
Frontiers in Cell and Developmental Biology|February 22, 2021
Consistent Long-Term Therapeutic Efficacy of Human Umbilical Cord Matrix-Derived Mesenchymal Stromal Cells After Myocardial Infarction Despite Individual Differences and Transient EngraftmentTiago L Laundos, Francisco Vasques-Nóvoa, Rita N Gomes, et al.
Frontiers in Cell and Developmental Biology|September 4, 2023
Corrigendum: Consistent long-term therapeutic efficacy of human umbilical cord matrix-derived mesenchymal stromal cells after myocardial infarction despite individual differences and transient engraftmentTiago L Laundos, Francisco Vasques-Nóvoa, Rita N Gomes, et al.
Cell Transplantation|February 1, 2014
The Human Umbilical Cord Tissue-Derived MSC Population UCX(®) Promotes Early Motogenic Effects on Keratinocytes and Fibroblasts and G-CSF-Mediated Mobilization of BM-MSCs When Transplanted In VivoJoana P Miranda, Elysse Filipe, Ana Sofia Fernandes, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cytotherapy|January 8, 2025
Smart Cell Therapy: an industry perspective on macrophages as living drugsDavid T Rodgers, Tatiana Novobrantseva, Rita N Barcia
Experimental Gerontology|January 5, 2002
Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cellsNicola S Dennett, Rita N Barcia, Julie D McLeod
Stem Cells Translational Medicine|May 16, 2019
Convergence of Cell Pharmacology and Drug DeliveryAyesha Aijaz, Natalie Vaninov, Ashley Allen, et al.
Stem Cells Translational Medicine|February 2, 2021
Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular applicationBrian O'Rourke, Sunny Nguyen, Arno W Tilles, et al.
Investigative Ophthalmology & Visual Science|September 18, 2010
Spontaneous bacterial keratitis in CD36 knockout miceJulia Klocke, Rita N Barcia, Susan Heimer, et al.
Scientific Reports|September 18, 2020
Author Correction: Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune CellsAshley Allen, Natalie Vaninov, Matthew Li, et al.
Scientific Reports|June 25, 2020
Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune CellsAshley Allen, Natalie Vaninov, Matthew Li, et al.
Frontiers in Cell and Developmental Biology|February 22, 2021
Consistent Long-Term Therapeutic Efficacy of Human Umbilical Cord Matrix-Derived Mesenchymal Stromal Cells After Myocardial Infarction Despite Individual Differences and Transient EngraftmentTiago L Laundos, Francisco Vasques-Nóvoa, Rita N Gomes, et al.
Frontiers in Cell and Developmental Biology|September 4, 2023
Corrigendum: Consistent long-term therapeutic efficacy of human umbilical cord matrix-derived mesenchymal stromal cells after myocardial infarction despite individual differences and transient engraftmentTiago L Laundos, Francisco Vasques-Nóvoa, Rita N Gomes, et al.
Cell Transplantation|February 1, 2014
The Human Umbilical Cord Tissue-Derived MSC Population UCX(®) Promotes Early Motogenic Effects on Keratinocytes and Fibroblasts and G-CSF-Mediated Mobilization of BM-MSCs When Transplanted In VivoJoana P Miranda, Elysse Filipe, Ana Sofia Fernandes, et al.
Pageof 2